Combined effect of anxiety disorder and insomnia on the risk of incident ADRD diagnosis - 07/06/26
, Joanne Salas c, Jinmyoung Cho d, Jeffrey F. Scherrer c, d, e, f
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
Anxiety disorders and insomnia are common modifiable conditions in older adults, but their independent and combined effects on the risk of incident Alzheimer’s disease and related dementias (ADRD) remain unclear.
Objectives |
To estimate the independent and combined associations of anxiety disorders and insomnia with the risk of incident ADRD.
Design |
Retrospective cohort study using an intention-to-treat approach with a 10-year follow-up period (2014–2023).
Setting |
De-identified electronic health record (EHR) data from 70 participating healthcare organizations within the TriNetX Research Network.
Participants |
Adults aged ≥50 years without prior dementia who had regular ambulatory care during a three-year baseline period (n = 1,868,790).
Measurements |
Anxiety and insomnia were identified using ICD-based algorithms and categorized into four exposure groups: neither condition, anxiety only, insomnia only, and both. Incident ADRD was defined by two or more diagnostic codes within 12 months. Entropy balancing controlled for confounding, and weighted Cox proportional hazards models estimated hazard ratios (HRs).
Results |
At baseline, 4.1% had anxiety only, 3.8% had insomnia only, and 1.1% had both. Over follow-up, 2.3% developed ADRD. In weighted models, insomnia alone (HR: 1.12; 95% CI: 1.06–1.19), anxiety alone (HR: 1.49; 95% CI: 1.39–1.60), and co-occurring anxiety and insomnia (HR: 1.31; 95% CI: 1.06–1.62) were each associated with higher ADRD risk compared with neither condition. No significant effect modification by age, sex, or race was observed.
Conclusions |
Anxiety and insomnia independently increase ADRD risk, though insomnia's contribution is very modest compared to the primary association demonstrated by anxiety. Co-occurrence does not confer additional risk beyond anxiety alone. Clinically, routine screening and treatment of anxiety and sleep disturbances represent actionable, broadly applicable strategies for ADRD prevention and healthy cognitive aging.
Le texte complet de cet article est disponible en PDF.Keywords : Anxiety disorders, Insomnia, Alzheimer’s disease and related dementias, TriNetX, Electronic health records (EHRs), Entropy balancing, Retrospective cohort study
Plan
Vol 13 - N° 8
Article 100621- octobre 2026 Retour au numéro
Article précédent
- Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment
- Elizabeth Kuhn, Luca Kleineidam, Melina Stark, Oliver Peters, Julian Hellmann-Regen, Lukas Preis, Daria Gref, Josef Priller, Eike Jakob Spruth, Maria Gemenetzi, Anja Schneider, Klaus Fliessbach, Jens Wiltfang, Claudia Bartels, Niels Hansen, Ayda Rostamzadeh, Emrah Düzel, Wenzel Glanz, Enise Incesoy, Katharina Buerger, Daniel Janowitz, Sophia Stöcklein, Robert Perneczky, Boris-Stephan Rauchmann, Stefan J. Teipel, Ingo Kilimann, Christoph Laske, Sebastian Sodenkamp, Annika Spottke, Marie Kronmüller, Sandra Roeske, Frederic Brosseron, Alfredo Ramirez, Matthis Synofzik, Matthias C. Schmid, Frank Jessen, Michael Wagner, Alzheimer’s Disease Neuroimaging Initiative, DELCODE study group
- Bidirectional causal relationships between plasma proteins, neuroimaging metrics and risk of Alzheimer's disease
- Xu Xu, Lintong Li, Wei Huang, Ying Yang, Xu Li, Pei Wang, Mengmeng Zhao, Huiliang Zhang, Chaoming Yuan
Bienvenue sur EM-consulte, la référence des professionnels de santé.